GT Biopharma (GTBP) Change in Inventory (2011 - 2012)
GT Biopharma (GTBP) posted quarterly Change in Inventory of -$59000.0 for Q4 2012, down 391.67% year-over-year from $20228.6 in Q1 2012, and down 164.13% quarter-over-quarter from $92000.0 in Q3 2012.
GT Biopharma (GTBP) Change in Inventory (2011 - 2012) Analysis & Trends
GT Biopharma (GTBP) has reported Change in Inventory for 2 consecutive years, with -$59000.0 the latest figure, recorded in Q4 2012.
- In Q4 2012, Change in Inventory fell 391.67% year-over-year to -$59000.0; the TTM figure through Dec 2012 stood at $21000.0 (changed N/A YoY), while the FY2014 annual figure was -$42000.0, down 147.06% from the prior year.
- Change in Inventory declined to -$59000.0 in Q4 2012 per GTBP's latest filing, from $92000.0 in the prior quarter.
- Across five years, Change in Inventory topped out at $92000.0 in Q3 2012 and bottomed at -$59000.0 in Q4 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 132.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 47.15 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -280,000.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 135.26 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 12.97 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | GT Biopharma | 8.64 Mn | 8.64 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2012 | -59,000.00 |
| Dec 31, 2012 | -59,000.00 |
| Sep 30, 2012 | 92,000.00 |
| Sep 30, 2012 | 92,000.00 |
| Dec 31, 2011 | -12,000.00 |
| Dec 31, 2011 | -12,000.00 |